Congenica Company

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

Last Funding Date: 2021-03-04
Investors Number: 14
Industry: Omics-Based Biomarkers
Last Funding Type: Series C
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Total Funding: 82364942
Funding Status: Late Stage Venture
Number Of Exists: 11-50
Estimated Revenue: 2.64
Founded Date: 2012-01-01